Avoiding Over-Engineering When Handling Drug Product Depending on the Formulation

Time: 3:25 pm
day: Conference Day Two


  • Ensuring alignment between laboratory investigation and CDMOs regarding handling of highly potent drug product
  • Uncovering specific parameters for how formulation affects the handling requirements
  • Understanding critical process steps that tend to be overengineered